S hi Yifeng is the general manager and a key shareholder of Imeik Technology Development, a leader in China's biomedical soft tissue repair industry. He joined the company early in its growth phase and has been pivotal in its operational management and market expansion. Imeik is renowned for its hyaluronic acid products and facial implants, capitalizing on China's booming medical aesthetics market.

Shi holds an MBA from Tsinghua University, one of China's most prestigious institutions. His leadership helped steer Imeik to a highly successful IPO on the Shenzhen Stock Exchange in 2020, which saw the company's stock price soar, minting several billionaires including Shi himself. He works closely with chairwoman Jian Jun to maintain Imeik's position as a premium brand in the aesthetic medicine sector.